Review



human pcsk9 catalog  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 94
      Buy from Supplier

    Structured Review

    R&D Systems human pcsk9 catalog
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Human Pcsk9 Catalog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 120 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pcsk9 catalog/product/R&D Systems
    Average 94 stars, based on 120 article reviews
    human pcsk9 catalog - by Bioz Stars, 2026-03
    94/100 stars

    Images

    1) Product Images from "Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies ☆ "

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies ☆

    Journal: American Journal of Preventive Cardiology

    doi: 10.1016/j.ajpc.2024.100896

    Baseline characteristics of patients before the initiation of PCSK9 mAb <xref ref-type= a ." title="Baseline characteristics of patients before the initiation of PCSK9 mAb a ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Baseline characteristics of patients before the initiation of PCSK9 mAb a .

    Techniques Used: Medications

    Lipids profile of study patients before and after initiation of PCSK9 mAb <xref ref-type= a ." title="... of study patients before and after initiation of PCSK9 mAb a ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Lipids profile of study patients before and after initiation of PCSK9 mAb a .

    Techniques Used:

    cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.
    Figure Legend Snippet: cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.

    Techniques Used:

    CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.
    Figure Legend Snippet: CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.

    Techniques Used: MTT Assay

    cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of PCSK9 mAb.
    Figure Legend Snippet: cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of PCSK9 mAb.

    Techniques Used:



    Similar Products

    catalog number 29698 h27h b 43  (Sino Biological)
    94
    Sino Biological catalog number 29698 h27h b 43
    Catalog Number 29698 H27h B 43, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/catalog number 29698 h27h b 43/product/Sino Biological
    Average 94 stars, based on 1 article reviews
    catalog number 29698 h27h b 43 - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier
    human pcsk9 catalog  (R&D Systems)
    94
    R&D Systems human pcsk9 catalog
    Baseline characteristics of patients before the initiation of <t> PCSK9 </t> mAb <xref ref-type= a ." width="250" height="auto" />
    Human Pcsk9 Catalog, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human pcsk9 catalog/product/R&D Systems
    Average 94 stars, based on 1 article reviews
    human pcsk9 catalog - by Bioz Stars, 2026-03
    94/100 stars
    		  Buy from Supplier

    Image Search Results


    Baseline characteristics of patients before the initiation of PCSK9 mAb <xref ref-type= a ." width="100%" height="100%">

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies ☆

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: Baseline characteristics of patients before the initiation of PCSK9 mAb a .

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques: Medications

    Lipids profile of study patients before and after initiation of PCSK9 mAb <xref ref-type= a ." width="100%" height="100%">

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies ☆

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: Lipids profile of study patients before and after initiation of PCSK9 mAb a .

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques:

    cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies ☆

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: cEPCs levels before and following the initiation of PCSK9 mAb. Percentage levels of (A) CD34 (+) /VEGFR-2 (+) and (B) CD133 (+) /VEGFR-2 (+) cells at 1 month and 3 months following the initiation of PCSK9 mAb.

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques:

    CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies ☆

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: CFUs and MTT assay levels before and following the initiation of PCSK9 mAb. Number of EPCs-CFUs (left) and MTT assay (right) performed before and after 1-month and 3-months of treatment with PCSK9 mAb.

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques: MTT Assay

    cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of PCSK9 mAb.

    Journal: American Journal of Preventive Cardiology

    Article Title: Circulating Endothelial Progenitor Cells in Patients with Established Cardiovascular Disease Treated with PCSK9 Monoclonal Antibodies ☆

    doi: 10.1016/j.ajpc.2024.100896

    Figure Lengend Snippet: cEPCs levels and function, at time 0, 1 month and 3 months following the initiation of PCSK9 mAb.

    Article Snippet: Levels of PCSK9 were measured using ELISA assays according to the manufacturer's recommendations (Human PCSK9 catalog number: DPC900 SPC900 PDPC900, R&D systems).

    Techniques: